Ahmedabad-based startup C3 Med-Tech has raised undisclosed funding from Industrial Metal Powders to launch advanced portable eye care equipment utilizing telemedicine and artificial intelligence (AI) for rapid and efficient eye checkups. This strategic investment is set to enhance immediate and accurate diagnosis of eye conditions, facilitating early interventions that can significantly reduce the risk of vision loss and blindness.
C3 Med-Tech is on a mission to make eye care accessible and affordable in India by developing cost-effective, portable eye screening devices. This funding milestone will enable the company to expand its reach across India and potentially to international markets. The expansion will focus on marketing efforts, team building, and further product development.
The company already boasts a portfolio of innovative, patented, and US FDA-approved eye care devices, including the C3 Vision-Portable Slit Lamp, C3 Smartphone Fundus Camera, and C3 Slit Lamp Imaging System. These devices are designed to diagnose a range of eye diseases, such as cataracts, diabetic retinopathy, and glaucoma. Additionally, C3 Med-Tech is developing the C3 Surgery Recording System, a unique product aimed at recording eye surgeries, thereby covering the full spectrum of eye care from initial screenings in resource-limited areas to surgical documentation in operating rooms.
C3 Med-Tech’s journey began at the Healthcare Technology Innovation Centre (HTIC) at the Indian Institute of Technology Madras. The startup has also received several grants, including the BIG’17 grant from the Department of Biotechnology, Government of India, and support from the IIT Madras Incubation Cell. The latest funding round was facilitated by the investment advisory firm INFSPL, based in Pune, India.
Steven Li, Managing Director at Hisense India, expressed confidence in the potential of C3 Med-Tech’s technology. “The integration of AI and telemedicine in eye care is a significant advancement. We are excited to see how C3 Med-Tech’s innovations will impact the field and improve patient outcomes.”
Pankaj Rana, CEO of Hisense India, also shared his enthusiasm: “I am thrilled to be part of this transformative journey. With this funding, C3 Med-Tech is poised to revolutionize eye care accessibility and affordability, making a profound impact on the healthcare landscape.”
C3 Med-Tech’s commitment to leveraging cutting-edge technology to enhance eye care aligns with its broader vision of making quality healthcare accessible to all, marking a significant step forward in the healthcare technology sector.
